News Focus
News Focus
icon url

DewDiligence

11/06/17 9:44 AM

#214886 RE: lgonber #213003

MLNT (Melinta Therapeutics—f/k/a CEMP) implements 1:5 reverse split in conjunction with closing of reverse merger (#msg-133699889):

https://www.sec.gov/Archives/edgar/data/1461993/000119312517333062/d474802d8k.htm